Psilocybin-assisted therapy for physician burnout
Part of Mental health clinical trials.
This study tests whether a psychedelic drug called psilocybin, combined with talk therapy, can help reduce burnout in doctors. It may help improve well-being and job satisfaction.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a faculty physician (not volunteer) aged 21 to 70.
- You have been experiencing burnout symptoms for more than 6 months.
- You are not currently taking antidepressants or other medications that could interact with psilocybin.
- You have no history of serious mental illness, such as schizophrenia or bipolar disorder.
- You have not used psilocybin or other psychedelics in the past 5 years.
- You have no heart disease, seizure disorder, or other major health problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if psilocybin (a psychedelic) combined with cognitive behavioral therapy (CBT) can help people with major depression. You would receive the psilocybin in a supervised setting and have talk therapy before and after.
This trial tests whether a treatment called psilocybin (a hallucinogen that can help with depression) combined with group therapy can improve symptoms of depression. It requires participants to have significant depression symptoms and a support person to drive them home after each session.
This study tests whether combining mindfulness training with a single dose of psilocybin (a psychedelic found in certain mushrooms) can help healthy adults. It aims to explore how these two approaches together might improve well-being.
This trial tests whether group psilocybin retreats can help healthcare workers who have lost meaning in their work and feel depressed. You would take psilocybin in a supportive retreat setting to see if it restores your sense of purpose and improves your mood.
This study tests whether a medicine called psilocybin, combined with talk therapy, can help people with hard-to-treat depression and a substance use problem. It aims to see if this treatment can improve mood and reduce substance use.
This trial tests if psilocybin, a psychedelic drug, can help people with long-term low back pain who also have depression. If you qualify, you'll receive psilocybin in a controlled setting, and researchers will see how it affects your pain and mood.
Hear when a new Burnout trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.